Literature DB >> 26890470

Local Transmission of Zika Virus--Puerto Rico, November 23, 2015-January 28, 2016.

Dana L Thomas, Tyler M Sharp, Jomil Torres, Paige A Armstrong, Jorge Munoz-Jordan, Kyle R Ryff, Alma Martinez-Quiñones, José Arias-Berríos, Marrielle Mayshack, Glenn J Garayalde, Sonia Saavedra, Carlos A Luciano, Miguel Valencia-Prado, Steve Waterman, Brenda Rivera-García.   

Abstract

Zika virus, a mosquito-borne flavivirus, spread to the Region of the Americas (Americas) in mid-2015, and appears to be related to congenital microcephaly and Guillain-Barré syndrome (1,2). On February 1, 2016, the World Health Organization (WHO) declared the occurrence of microcephaly cases in association with Zika virus infection to be a Public Health Emergency of International Concern.* On December 31, 2015, Puerto Rico Department of Health (PRDH) reported the first locally acquired (index) case of Zika virus disease in a jurisdiction of the United States in a patient from southeastern Puerto Rico. During November 23, 2015-January 28, 2016, passive and enhanced surveillance for Zika virus disease identified 30 laboratory-confirmed cases. Most (93%) patients resided in eastern Puerto Rico or the San Juan metropolitan area. The most frequently reported signs and symptoms were rash (77%), myalgia (77%), arthralgia (73%), and fever (73%). Three (10%) patients were hospitalized. One case occurred in a patient hospitalized for Guillain-Barré syndrome, and one occurred in a pregnant woman. Because the most common mosquito vector of Zika virus, Aedes aegypti, is present throughout Puerto Rico, Zika virus is expected to continue to spread across the island. The public health response in Puerto Rico is being coordinated by PRDH with assistance from CDC. Clinicians in Puerto Rico should report all cases of microcephaly, Guillain-Barré syndrome, and suspected Zika virus disease to PRDH. Other adverse reproductive outcomes, including fetal demise associated with Zika virus infection, should be reported to PRDH. To avoid infection with Zika virus, residents of and visitors to Puerto Rico, particularly pregnant women, should strictly follow steps to avoid mosquito bites, including wearing pants and long-sleeved shirts, using permethrin-treated clothing and gear, using an Environmental Protection Agency (EPA)-registered insect repellent, and ensuring that windows and doors have intact screens.

Entities:  

Mesh:

Year:  2016        PMID: 26890470     DOI: 10.15585/mmwr.mm6506e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  53 in total

1.  Implementation and Evaluation of Guillain-Barré Syndrome Surveillance in Puerto Rico during the 2016 Zika Virus Epidemic.

Authors:  Chelsea G Major; Emilio Dirlikov; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge Muñoz-Jordán; Candimar Colón-Sánchez; Myriam García-Negrón; Marangely Olivero-Segarra; Graciela Malavé-González; Dana L Thomas; Carlos A Luciano; Stephen H Waterman; James Sejvar; Tyler M Sharp; Brenda Rivera-García
Journal:  P R Health Sci J       Date:  2018-12       Impact factor: 0.705

2.  Clinical Features of Guillain-Barré Syndrome With vs Without Zika Virus Infection, Puerto Rico, 2016.

Authors:  Emilio Dirlikov; Chelsea G Major; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge L Muñoz-Jordan; Candimar Colon-Sanchez; Myriam Garcia; Marangely Olivero-Segarra; Graciela Malave; Gloria M Rodríguez-Vega; Dana L Thomas; Stephen H Waterman; James J Sejvar; Carlos A Luciano; Tyler M Sharp; Brenda Rivera-García
Journal:  JAMA Neurol       Date:  2018-09-01       Impact factor: 18.302

3.  Entomological Investigation of Aedes aegypti In Neighborhoods With Confirmed Human Arbovirus Infection In Puerto Rico.

Authors:  Gilberto E Felix; Roberto Barrera; Jesus Vazquez; Kyle R Ryff; Jorge L Munoz-Jordan; Katia Y Matias; Ryan R Hemme
Journal:  J Am Mosq Control Assoc       Date:  2018-09       Impact factor: 0.917

Review 4.  Zika virus-associated Guillain-Barré syndrome: a warning for critical care physicians.

Authors:  Guillaume Thiery; Ruddy Valentino; Hossein Meddhaoui
Journal:  Intensive Care Med       Date:  2016-04-27       Impact factor: 17.440

Review 5.  Zika clinical updates: implications for pediatrics.

Authors:  Kristina Adachi; Karin Nielsen-Saines
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

6.  Development and Characterization of Recombinant Virus Generated from a New World Zika Virus Infectious Clone.

Authors:  James Weger-Lucarelli; Nisha K Duggal; Kristen Bullard-Feibelman; Milena Veselinovic; Hannah Romo; Chilinh Nguyen; Claudia Rückert; Aaron C Brault; Richard A Bowen; Mark Stenglein; Brian J Geiss; Gregory D Ebel
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

7.  Cost projections for implementation of safety interventions to prevent transfusion-transmitted Zika virus infection in the United States.

Authors:  Katherine D Ellingson; Mathew R P Sapiano; Kathryn A Haass; Alexandra A Savinkina; Misha L Baker; Richard A Henry; James J Berger; Matthew J Kuehnert; Sridhar V Basavaraju
Journal:  Transfusion       Date:  2017-06       Impact factor: 3.157

8.  Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.

Authors:  Zhong Li; Srilatha Sakamuru; Ruili Huang; Matthew Brecher; Cheri A Koetzner; Jing Zhang; Haiying Chen; Cheng-Feng Qin; Qing-Yu Zhang; Jia Zhou; Laura D Kramer; Menghang Xia; Hongmin Li
Journal:  Antiviral Res       Date:  2017-12-27       Impact factor: 5.970

9.  JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo.

Authors:  Zhong Li; Jimin Xu; Yuekun Lang; Xiaoyu Fan; Lili Kuo; Lianna D'Brant; Saiyang Hu; Subodh Kumar Samrat; Nicole Trudeau; Anil M Tharappel; Natasha Rugenstein; Cheri A Koetzner; Jing Zhang; Haiying Chen; Laura D Kramer; David Butler; Qing-Yu Zhang; Jia Zhou; Hongmin Li
Journal:  ACS Infect Dis       Date:  2020-09-21       Impact factor: 5.084

Review 10.  Zika virus: History, emergence, biology, and prospects for control.

Authors:  Scott C Weaver; Federico Costa; Mariano A Garcia-Blanco; Albert I Ko; Guilherme S Ribeiro; George Saade; Pei-Yong Shi; Nikos Vasilakis
Journal:  Antiviral Res       Date:  2016-03-18       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.